| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 58.1K | $57.2K | $0.98 | Jan 1, 2025 | Direct |
| Xilio Therapeutics, Inc. | Chief Financial Officer | Common stock | 12.4K | $12.2K | $0.98 | Jan 2, 2025 | Direct |
| Xilio Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 251K | Jan 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | Jan 1, 2025 | 4 | -$6.84K | 4 | Jan 3, 2025 | Chief Financial Officer |
| XLO | Xilio Therapeutics, Inc. | Aug 3, 2024 | 1 | $0 | 4 | Aug 6, 2024 | Chief Operating Officer |
| XLO | Xilio Therapeutics, Inc. | May 1, 2024 | 1 | $0 | 4 | May 3, 2024 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Aug 16, 2023 | 1 | $0 | 4 | Aug 18, 2023 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Aug 3, 2023 | 1 | $0 | 4 | Aug 7, 2023 | Chief Operating Officer |
| XLO | Xilio Therapeutics, Inc. | Aug 3, 2023 | 0 | $0 | 3 | Aug 7, 2023 | Chief Operating Officer |